Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) α chain

Molecular Biology of the Cell

Volumn 11, Issue 4, 2000, Pages 1129-1142

  Antonelli, Valeria ^a,b   Bernasconi, Francesca ^a,b   Wong, Yung H ^c   Vallar, Lucia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RAF PROTEIN; RAS PROTEIN; TYROSINE KINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0034088389     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.11.4.1129     Document Type: Article

References (70)

1. Alessi, D.R., Cohen, P., Ashworth, A., Cowley, S., Leevers, S.J., and Marshall, C.J. (1995). Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255, 279-290.
2. Baffy, G., Yang, L., Raj, S., Manning, D.R., and Williamson, J.R. (1994) G protein coupling to the thrombin receptor in Chinese hamster lung fibroblasts. J. Biol. Chem. 269, 8483-8487
3. Barnier, J.V., Papin, C., Eychène, A., Lecoq, O., and Calothy, G. (1995). The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem. 270, 23381-23389.
4. Boguski, M.S., and McCormick, F. (1993). Proteins regulating Ras and its relatives. Nature 366, 643-654.
5. Bos, J.L., and Zwartkruis, F.J.T. (1999). Rhapsody in G proteins. Nature 400, 820-821.
6. Campbell, S L., Khosravi-Far, R., Rossman, K.L., Clark, G.J., and Der, C.J. (1998). Increasing complexity of Ras signaling. Oncogene 17, 1395-1413.
7. Cobb, M.H., and Goldsmith, E.J. (1995). How MAP kinases are regulated. J. Biol. Chem. 270, 14843-14846.
8. qα mutational activation and coupling to receptors and phospholipase C. J. Biol. Chem. 267, 31-34.
9. Daaka, Y., Luttrell, L.M., Ahn, S., Della Rocca, G.J., Ferguson, S.S.G., Caron, M.G., and Lefkowitz, R.J. (1998). Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J. Biol. Chem. 273, 685-688.
10. Davis, R.J. (1993). The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556.
11. q-α potentiates platelet-derived growth factor-stimulated mitogenesis in confluent cell cultures. J. Biol. Chem. 269, 19671-19674.
12. α13 in Chinese hamster ovary cells J. Biol. Chem. 268, 5676-5685
13. Dhanasekaran, N., Tsim, S.T., Dermott, J.M., and Onesime, D. (1998). Regulation of cell proliferation by G proteins. Oncogene 17, 1383-1394.
14. Diversé-Pierluissi, M., Remmers, A.E., Neubig, R.R., and Dunlap, K. (1997). Novel form of crosstalk between G protein and tyrosine kinase pathways. Proc. Natl. Acad. Sci. USA 94, 5417-5421.
15. Fujitani, Y., and Bertrand, C. (1997). ET-1 cooperates with EGF to induce mitogenesis via a PTX-sensitive pathway in airway smooth muscle cells. Am J. Physiol. 272, 1492-1498.
16. Gallego, C., Gupta, S.K., Heasley, L.E., Qian, N.X., and Johnson, G.L. (1992). Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and Rat-1a cells. Proc. Natl. Acad. Sci. USA 89, 7355-7359.
17. Garnovskaya, M.N., van Biesen, T., Hawe, B., Casanas Ramos, S., Lefkowitz, R.J., and Raymond, J.R. (1996). Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein βγ-subunit-initiated pathway. Biochemistry 35, 13716-13722.
18. Garrington, T.P., and Johnson, G.L. (1999). Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11, 211-218.
19. Gupta, S.K., Gallego, C., Lowndes, J.M., Pleiman, C.M., Sable, C., Eisfelder, B.J., and Johnson, G.L. (1992). Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes. Mol. Cell. Biol. 12, 190-197.
20. Gutkind, J.S. (1998). The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 1839-1842.
21. Hackel, P.O., Zwick, E., Prenzel, N., and Ullrich, A. (1999). Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 11, 184-189.
22. 1-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization. J. Neurochem. 71, 1024-1033.
23. q-mediated mitogen-activated protein kinase activation. J. Biol. Chem. 270, 17148-17153.
24. i2 protein have opposite effects on proliferation of NIH 3T3 cells Proc. Natl. Acad. Sci. USA 88, 10455-10459.
25. o. Proc. Natl. Acad. Sci. USA 95, 3269-3274.
26. o with Rap1 GTPase-activating protein. J. Biol. Chem. 274, 21507-21510.
27. Knall, C., Young, S., Nick, J.A., Buhl, A.M., Worthen, G.S., and Johnson, G.L. (1996). Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J. Biol. Chem. 271, 2832-2838.
28. o-α subunit expressed in NIH-3T3 cells induces transformation. J. Biol. Chem. 267, 23183-23188.
29. o protein induces oocyte maturation. Proc. Natl. Acad. Sci. USA 88, 5182-5186.
30. i2 antibodies. J. Biol. Chem. 267, 691-694.
31. s and stimulate adenylyl cyclase in human pituitary tumors. Nature 340, 692-696.
32. i2 in GH4C1 pituitary cells. J. Biol. Chem 269, 13880-13886.
33. Luttrell, L.M., Daaka, Y., and Lefkowitz, R.J. (1999). Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr. Opin. Cell Biol. 11, 177-183.
34. Lyons, J., et al. (1990). Two G protein oncogenes in human endocrine tumors. Science 249, 655-659.
35. Marais, R., Light, Y., Paterson, H.F., Mason, C.S., and Marshall, C.J. (1997). Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic Ras and tyrosine kinases. J. Biol. Chem. 272, 4378-4383.
36. Marais, R., and Marshall, C.J. (1996). Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv. 27, 101-125.
37. Marshall, C.J. (1994). MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 4, 82-89.
38. mapk. Mol. Biol. Cell 3, 63-71.
39. Meloche, S., Seuwen, K., Pages, G., and Pouyssegur, J. (1992b). Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6, 845-854.
40. o protein as signal transducer in the pertussis toxin-sensitive phosphatidylinositol pathway. Nature 343, 79-82.
41. i. Nature 400, 891-894.
42. Morrison, D.K., and Cutler, R.E., Jr. (1997). The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9, 174-179.
43. Neer, E.J. (1995). Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80, 249-257.
44. i2-mediated activation of the MAP kinase cascade. Mol. Biol. Cell 6, 1685-1695.
45. i2 induces neoplastic transformation of Rat-1 cells. Proc. Natl. Acad. Sci. USA 88, 7031-7035.
46. Peraldi, P., Frodin, M., Barnier, J.V., Calleja, V., Scimeca, J.C., Filloux, C., Calothy, G., Van Obberghen, E. (1995). Regulation of the MAP kinase cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. FEBS Lett. 357, 290-296.
47. Pouyssegur, J., and Seuwen, K. (1992). Transmembrane receptors and intracellular pathways that control cell proliferation. Annu. Rev. Physiol. 54, 195-210.
48. Renshaw, M.W., Ren, X.D., and Schwartz, M.A. (1997). Growth factor activation of MAP kinase requires cell adhesion. EMBO J. 16, 5592-5599.
49. Reuter, C.W.M., Catling, A.D., Jelinek, T., and Weber, M.J. (1995). Biochemical analysis of MEK activation in NIH3T3 fibroblasts. J. Biol. Chem. 270, 7644-7655.
50. Rosario, M., Paterson, H.F., and Marshall, C.J. (1999) Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J. 18, 1270-1279.
51. Schlessinger, J. (1994). SH2/SH3 signaling proteins. Curr. Opin. Genet. Dev. 4, 25-30.
52. ras-dependent pathway. J. Biol. Chem. 274, 25833-25841.
53. Sunahara, R.K., Dessauer, C.W., and Gilman, A.G. (1996). Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461-480.
54. Toker, A., and Cantley, L.C. (1997). Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673-676.
55. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., and Loriolle, F. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
56. Ui, M., Okada, T., Hazeki, K., and Hazeki, O. (1995). Wortmanmn as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20, 303-307.
57. Vaillancourt, R.R., Gardner, A.M., and Johnson, G.L. (1994). B-Raf-dependent regulation of the MEK-1/mitogen-activated protein kinase pathway in PC12 cells and regulation by cyclic AMP. Mol. Cell. Biol. 14, 6522-6530.
58. Vallar, L. (1996). Oncogenic role of heterotrimeric G proteins. Cancer Surv. 27, 325-338.
59. o-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J. Biol. Chem. 271, 1266-1269.
60. van Biesen, T., Luttrell, L.M., Hawes, B.E., and Lefkowitz, R.J. (1996b). Mitogenic signaling via G protein-coupled receptors. Endoer. Rev. 17, 698-714.
61. Vlahos, C.J., Matter, W.F., Hui, K.Y., and Brown, R.F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
62. Vossler, M.R., Yao, H., York, R.D., Pan, M.G., Rim, C.S., and Stork, P.J.S. (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1-dependent pathway. Cell 89, 73-82.
63. mapk (ERK1) by α-thrombin and thrombin-receptor peptide agonist. Biochem. J. 289, 209-214.
64. 13 proteins induce neoplastic transformation of Rat-1 fibroblasts. Oncogene 9, 2559-2565.
65. 2L dopamine receptors in NS20Y neuroblastoma cells. J. Neurosci. 18, 8692-8699.
66. Wennstrom, S., and Downward, J. (1999). Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol. Cell. Biol. 19, 4279-4288.
67. z-mediated hormonal inhibition of cyclic AMP accumulation. Science 255, 339-342.
68. WyUe, P.G., Challiss, R.A.J., and Blank, J.L. (1999). Regulation of extracellular signal-regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors. Biochem. J. 338, 619-628.
69. Xu, S., Khoo, S., Dang, A., Wirt, S., Do, V., Zhen, E., Schaefer, E.M., and Cobb, M.H. (1997). Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism. Mol. Endocrinol. 11, 1618-1625.
70. York, R.D., Yao, H., Dillon, T., Ellig, C.L., Eckert, S.P., McCleskey, E.W., and Stork, P.J.S. (1998). Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392, 622-626.